Phentermine
Sold as Phentolene, Musalos, Minex, Inocrave, Duromine, Minobese forte diffucaps
Background
Registration
- Applicants
- 4
- Registrations
- 11
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Crux Pharmaceuticals (Pty) Ltd | Phentolene | 15 mg, 30 mg | 530130, 530131 | S5 | None |
| Pharma Dynamics (Pty) Ltd | Musalos, Minex | 15 mg, 30 mg | 530711, 530712, 530713.711, 530714.712 | S5 | None |
| Inova Pharmaceuticals (Pty) Ltd | Inocrave, Duromine | 15, 30 | 550891, 550892, B0657, B0658 | S5 | None |
| The Premier Pharmaceutical Co LtdCancelled | Minobese forte diffucaps | Not stated | J0101 | S5 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Phentolene 15 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE 15,0 mg | 15 mg | 53013053/11.3/0130 | Registered | S5 | None |
| Phentolene 30 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE 30,0 mg | 30 mg | 53013153/11.3/0131 | Registered | S5 | None |
| Musalos 15 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE EQUIVALENT TO PHENTERMINE 15,0 mg | 15 mg | 53071153/11.3/0711 | Registered | S5 | None |
| Musalos 30 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE EQUIVALENT TO PHENTERMINE 30,0 mg | 30 mg | 53071253/11.3/0712 | Registered | S5 | None |
| Minex 15 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE EQUIVALENT TO PHENTERMINE 15,0 mg | 15 mg | 530713.71153/11.3/0713.711 | Registered | S5 | None |
| Minex 30 MG EACH CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE EQUIVALENT TO PHENTERMINE 30,0 mg | 30 mg | 530714.71253/11.3/0714.712 | Registered | S5 | None |
| Inocrave 15 EACH CAPSULE CONTAINS PHENTERMINE 15,0 mg | 15 | 55089155/11.3/0891 | Registered | S5 | None |
| Inocrave 30 EACH CAPSULE CONTAINS PHENTERMINE 30,0 mg | 30 | 55089255/11.3/0892 | Registered | S5 | None |
| Duromine 15 EACH CAPSULE CONTAINS PHENTERMINE A 15,0 mg | 15 | B0657 | Old Medicine | S5 | None |
| Duromine 30 EACH CAPSULE CONTAINS PHENTERMINE A 30,0 mg | 30 | B0658 | Old Medicine | S5 | None |
| Minobese forte diffucaps EACH CONTROLLED RELEASE CAPSULE CONTAINS PHENTERMINE HYDROCHLORIDE 30 MG | Not listed | J0101J/11.3/101 | Cancelled | S5 | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Phentermine hydrochloride
S5: Phentermine
Consolidated Schedules 06 July 2026, line 9641
Pharmacological class: Anorexigenics. (class 11.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.